Terms: = Sarcomas AND PAX7, PAX7B, 5081, ENSG00000009709, P23759, HUP1 AND Prognosis
36 results:
1. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
[TBL] [Abstract] [Full Text] [Related]
2. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
[TBL] [Abstract] [Full Text] [Related]
3. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
[TBL] [Abstract] [Full Text] [Related]
4. [Alveolar rhabdomyosarcoma: novel surrogate markers associated with oncogenic translocation].
Tarakanova AV; Sharlay AS; Konovalov DM
Arkh Patol; 2023; 85(1):10-15. PubMed ID: 36785957
[TBL] [Abstract] [Full Text] [Related]
5. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
[TBL] [Abstract] [Full Text] [Related]
6. PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.
Raze T; Lapouble E; Lacour B; Guissou S; Defachelles AS; Gaspar N; Delattre O; Pierron G; Desandes E
Pediatr Blood Cancer; 2023 Apr; 70(4):e30228. PubMed ID: 36722003
[TBL] [Abstract] [Full Text] [Related]
7. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and pax7-FOXO1].
Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
[TBL] [Abstract] [Full Text] [Related]
8. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
[TBL] [Abstract] [Full Text] [Related]
9. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract] [Full Text] [Related]
10. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor".
Cloutier JM; Charville GW; Mertens F; Sukov W; Fritchie K; Perry KD; Edgar M; Rowsey RA; Folpe AL
Mod Pathol; 2021 Apr; 34(4):758-769. PubMed ID: 33318583
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies.
Azorsa DO; Bode PK; Wachtel M; Cheuk ATC; Meltzer PS; Vokuhl C; Camenisch U; Khov HL; Bode B; Schäfer BW; Khan J
Mod Pathol; 2021 Apr; 34(4):748-757. PubMed ID: 33299109
[TBL] [Abstract] [Full Text] [Related]
12. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
[TBL] [Abstract] [Full Text] [Related]
13. FAK Signaling in Rhabdomyosarcoma.
Perrone C; Pomella S; Cassandri M; Braghini MR; Pezzella M; Locatelli F; Rota R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182556
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Ono T; Toki S; Kobayashi E; Arakawa A; Sugiyama M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Oct; 33(4):1311-1320. PubMed ID: 32715445
[TBL] [Abstract] [Full Text] [Related]
15. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas.
Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M
Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794
[TBL] [Abstract] [Full Text] [Related]
16. A Review of the Role of Cytogenetics in the Diagnosis of Orbital Rhabdomyosarcoma.
Cortes Barrantes P; Jakobiec FA; Dryja TP
Semin Ophthalmol; 2019; 34(4):243-251. PubMed ID: 31146616
[TBL] [Abstract] [Full Text] [Related]
17. Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M; Stegmaier S; Vokuhl C; Seitz G; von Kalle T; Scheer M; Münter M; Bielack SS; Weclawek-Tompol J; Ladenstein R; Niggli F; Ljungman G; Fuchs J; Hettmer S; Koscielniak E; Klingebiel T;
Pediatr Blood Cancer; 2019 Jun; 66(6):e27652. PubMed ID: 30762282
[TBL] [Abstract] [Full Text] [Related]
18. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
[TBL] [Abstract] [Full Text] [Related]
19. Pleural Alveolar Rhabdomyosarcoma.
Lu H; Qin J; Wang Z
Clin Lab; 2017 Oct; 63(10):1745-1748. PubMed ID: 29035460
[TBL] [Abstract] [Full Text] [Related]
20. The RhoE/ROCK/ARHGAP25 signaling pathway controls cell invasion by inhibition of Rac activity.
Thuault S; Comunale F; Hasna J; Fortier M; Planchon D; Elarouci N; De Reynies A; Bodin S; Blangy A; Gauthier-Rouvière C
Mol Biol Cell; 2016 Sep; 27(17):2653-61. PubMed ID: 27413008
[TBL] [Abstract] [Full Text] [Related]
[Next]
